Skip to main content
    • Aa
    • Aa
  • Access
  • Cited by 8
  • Cited by
    This article has been cited by the following publications. This list is generated based on data provided by CrossRef.

    Pathak- Gandhi, Namyata and Vaidya, Ashok D.B. 2016. Management of Parkinson's disease in Ayurveda: Medicinal plants and adjuvant measures. Journal of Ethnopharmacology,

    Mythri, Rajeswara Babu Joshi, Apurva Kumar and Bharath, Muchukunte Mukunda Srinivas 2015. Bioactive Nutraceuticals and Dietary Supplements in Neurological and Brain Disease.

    Alladi, Phalguni Anand 2013. Neurostereology.

    Gupta, Subash C. Sung, Bokyung Kim, Ji Hye Prasad, Sahdeo Li, Shiyou and Aggarwal, Bharat B. 2013. Multitargeting by turmeric, the golden spice: From kitchen to clinic. Molecular Nutrition & Food Research, Vol. 57, Issue. 9, p. 1510.

    Herraiz, Tomás Guillén, Hugo and Galisteo, Juan 2013. Metabolite Profile Resulting from the Activation/Inactivation of 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 2-Methyltetrahydro-β-carboline by Oxidative Enzymes. BioMed Research International, Vol. 2013, p. 1.

    Udani, Jay K 2013. Effects of SuperUlam on Supporting Concentration and Mood: A Randomized, Double-Blind, Placebo-Controlled Crossover Study. Evidence-Based Complementary and Alternative Medicine, Vol. 2013, p. 1.

    Darvesh, Altaf S Carroll, Richard T Bishayee, Anupam Novotny, Nicholas A Geldenhuys, Werner J and Van der Schyf, Cornelis J 2012. Curcumin and neurodegenerative diseases: a perspective. Expert Opinion on Investigational Drugs, Vol. 21, Issue. 8, p. 1123.

    Koppula, Sushruta Kumar, Hemant More, Sandeep Vasant Kim, Byung Wook Kim, In Su and Choi, Dong-Kug 2012. Recent Advances on the Neuroprotective Potential of Antioxidants in Experimental Models of Parkinson’s Disease. International Journal of Molecular Sciences, Vol. 13, Issue. 12, p. 10608.


Chronic dietary supplementation with turmeric protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-mediated neurotoxicity in vivo: implications for Parkinson's disease

  • Rajeswara Babu Mythri (a1), Jayagopalan Veena (a2), G. Harish (a1), B. S. Shankaranarayana Rao (a2) and M. M. Srinivas Bharath (a1)
  • DOI:
  • Published online: 08 April 2011

Multiple pathways including oxidative stress and mitochondrial damage are implicated in neurodegeneration during Parkinson's disease (PD). The current PD drugs provide only symptomatic relief and have limitations in terms of adverse effects and inability to prevent neurodegeneration. Therefore, there is a demand for novel compound(s)/products that could target multiple pathways and protect the dying midbrain dopaminergic neurons, with potential utility as adjunctive therapy along with conventional drugs. Turmeric is a spice used in traditional Indian cuisine and medicine with antioxidant, anti-inflammatory and potential neuroprotective properties. To explore the neuroprotective property of turmeric in PD, mice were subjected to dietary supplementation with aqueous suspensions of turmeric for 3 months, mimicking its chronic consumption and challenged in vivo with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Brain samples from untreated and treated groups were characterised based on mitochondrial complex I (CI) activity, protein nitration and tyrosine hydroxylase immunoreactivity. Chronic turmeric supplementation induced the enzyme activity of γ-glutamyl cysteine ligase, which in turn increased glutathione levels and protected against peroxynitrite-mediated inhibition of brain CI. These mice were also protected against MPTP-mediated protein nitration, CI inhibition and degeneration of substantia nigra neurons in the brain. We conclude that chronic dietary consumption of turmeric protects the brain against neurotoxic insults, with potential application in neurodegeneration. Further characterisation of the active constituents of turmeric that potentially promote neuroprotection could improve the utility of dietary turmeric in brain function and disease.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle.

      Note you can select to send to either the or variations. ‘’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Chronic dietary supplementation with turmeric protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-mediated neurotoxicity in vivo: implications for Parkinson's disease
      Available formats
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your Dropbox account. Find out more about sending content to Dropbox.

      Chronic dietary supplementation with turmeric protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-mediated neurotoxicity in vivo: implications for Parkinson's disease
      Available formats
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your Google Drive account. Find out more about sending content to Google Drive.

      Chronic dietary supplementation with turmeric protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-mediated neurotoxicity in vivo: implications for Parkinson's disease
      Available formats
Corresponding author
*Corresponding author: Professor M. M. Srinivas Bharath, fax +91 80 26564830, email
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

2MM Bharath (2008) Therapeutic strategies in Parkinson's disease. Recent Patents on Endocrine, Metabolic & Immune Drug Discovery 2, 135147.

4A Goel , AB Kunnumakkara & BB Aggarwal (2008) Curcumin as ‘Curecumin’: from kitchen to clinic. Biochem Pharmacol 75, 787809.

5RB Mythri , B Jagatha , N Pradhan , (2007) Mitochondrial complex I inhibition in Parkinson's disease: how can curcumin protect mitochondria? Antioxid Redox Signal 9, 399408.

6G Harish , C Venkateshappa , RB Mythri , (2010) Bioconjugates of curcumin display improved protection against glutathione depletion mediated oxidative stress in a dopaminergic neuronal cell line: implications for Parkinson's disease. Bioorg Med Chem 18, 26312638.

7B Jagatha , RB Mythri , S Vali , (2008) Curcumin treatment alleviates the effects of glutathione depletion in vitro and in vivo: therapeutic implications for Parkinson's disease explained via in silico studies. Free Radic Biol Med 44, 907917.

8C Ramassamy (2006) Emerging role of polyphenolic compounds in the treatment of neurodegenerative diseases: a review of their intracellular targets. Eur J Pharmacol 545, 5164.

9HP Ammon & MA Wahl (1991) Pharmacology of Curcuma longa. Planta Med 57, 17.

10P Anand , AB Kunnumakkara , RA Newman , (2007) Bioavailability of curcumin: problems and promises. Mol Pharm 4, 807818.

11RA Sharma , WP Steward & AJ Gescher (2007) Pharmacokinetics and pharmacodynamics of curcumin. Adv Exp Med Biol 595, 453470.

12S Balaji & B Chempakam (2009) Pharmacokinetics prediction and drugability assessment of diphenylheptanoids from turmeric (Curcuma longa L.). Med Chem 5, 130138.

13MA Ortiz-Ortiz , JM Moran , LM Ruiz-Mesa , (2010) Curcumin exposure induces expression of the Parkinson's disease-associated leucine-rich repeat kinase 2 (LRRK2) in rat mesencephalic cells. Neurosci Lett 468, 120124.

14MA Ortiz-Ortiz , JM Moran , JM Bravosanpedro , (2009) Curcumin enhances paraquat-induced apoptosis of N27 mesencephalic cells via the generation of reactive oxygen species. Neurotoxicology 30, 10081018.

15RF Tayyem , DD Heath , WK Al-Delaimy , (2006) Curcumin content of turmeric and curry powders. Nutr Cancer 55, 126131.

16XL Hou , K Takahashi , N Kinoshita , (2007) Possible inhibitory mechanism of Curcuma drugs on CYP3A4 in 1alpha,25 dihydroxyvitamin D3 treated Caco-2 cells. Int J Pharm 337, 169177.

17T Ahmed & AH Gilani (2009) Inhibitory effect of curcuminoids on acetylcholinesterase activity and attenuation of scopolamine-induced amnesia may explain medicinal use of turmeric in Alzheimer's disease. Pharmacol Biochem Behav 91, 554559.

18GF Seelig & A Meister (1985) Glutathione biosynthesis; gamma-glutamylcysteine synthetase from rat kidney. Methods Enzymol 113, 379390.

20J Veena , BN Srikumar , K Mahati , (2009) Enriched environment restores hippocampal cell proliferation and ameliorates cognitive deficits in chronically stressed rats. J Neurosci Res 87, 831843.

21J Veena , BN Srikumar , TR Raju , (2009) Exposure to enriched environment restores the survival and differentiation of new born cells in the hippocampus and ameliorates depressive symptoms in chronically stressed rats. Neurosci Lett 455, 178182.

22M Ebadi & SK Sharma (2003) Peroxynitrite and mitochondrial dysfunction in the pathogenesis of Parkinson's disease. Antioxid Redox Signal 5, 319335.

23A Abeliovich & M Flint Beal (2006) Parkinsonism genes: culprits and clues. J Neurochem 99, 10621072.

24F Cicchetti , J Drouin-Ouellet & RE Gross (2009) Environmental toxins and Parkinson's disease: what have we learned from pesticide-induced animal models? Trends Pharmacol Sci 30, 475483.

25MP Mattson (2003) Gene–diet interactions in brain aging and neurodegenerative disorders. Ann Intern Med 139, 441444.

26NE Bharucha , EP Bharucha , AE Bharucha , (1988) Prevalence of Parkinson's disease in the Parsi community of Bombay, India. Arch Neurol 45, 13211323.

27U Muthane , TC Yasha & SK Shankar (1998) Low numbers and no loss of melanized nigral neurons with increasing age in normal human brains from India. Ann Neurol 43, 283287.

28PA Alladi , A Mahadevan , TC Yasha , (2009) Absence of age-related changes in nigral dopaminergic neurons of Asian Indians: relevance to lower incidence of Parkinson's disease. Neuroscience 159, 236245.

29M Ragothaman , UA Murgod , G Gururaj , (2003) Lower risk of Parkinson's disease in an admixed population of European and Indian origins. Mov Disord 18, 912914.

31K Srinivasan (2005) Plant foods in the management of diabetes mellitus: spices as beneficial antidiabetic food adjuncts. Int J Food Sci Nutr 56, 399414.

33P Anand , C Sundaram , S Jhurani , (2008) Curcumin and cancer: an ‘old-age’ disease with an ‘age-old’ solution. Cancer Lett 267, 133164.

34SJ Kim , TG Son , HR Park , (2008) Curcumin stimulates proliferation of embryonic neural progenitor cells and neurogenesis in the adult hippocampus. J Biol Chem 283, 1449714505.

35Y Xu , B Ku , L Cui , (2007) Curcumin reverses impaired hippocampal neurogenesis and increases serotonin receptor 1A mRNA and brain-derived neurotrophic factor expression in chronically stressed rats. Brain Res 1162, 918.

36S Lalitha & R Selvam (1999) Prevention of H2O2-induced red blood cell lipid peroxidation and hemolysis by aqueous extracted turmeric. Asia Pac J Clin Nutr 8, 113114.

38J Wang , XX Du , H Jiang , (2009) Curcumin attenuates 6-hydroxydopamine-induced cytotoxicity by anti-oxidation and nuclear factor-kappa B modulation in MES23.5 cells. Biochem Pharmacol 78, 178183.

39MF Beal (2009) Therapeutic approaches to mitochondrial dysfunction in Parkinson's disease. Parkinsonism Relat Disord 15, Suppl. 3, S189S194.

40R Pal , EA Cristan , K Schnittker , (2010) Rescue of ER oxidoreductase function through polyphenolic phytochemical intervention: implications for subcellular traffic and neurodegenerative disorders. Biochem Biophys Res Commun 392, 567571.

41S Yang , D Zhang , Z Yang , (2008) Curcumin protects dopaminergic neuron against LPS induced neurotoxicity in primary rat neuron/glia culture. Neurochem Res 33, 20442053.

43H Sawada , M Ibi , T Kihara , (2002) Estradiol protects dopaminergic neurons in a MPP+Parkinson's disease model. Neuropharmacology 42, 10561064.

44S Yu , W Zheng , N Xin , (2010) Curcumin prevents dopaminergic neuronal death through inhibition of the c-Jun N-terminal kinase pathway. Rejuvenation Res 13, 5564.

45A Rajeswari & M Sabesan (2008) Inhibition of monoamine oxidase-B by the polyphenolic compound, curcumin and its metabolite tetrahydrocurcumin, in a model of Parkinson's disease induced by MPTP neurodegeneration in mice. Inflammopharmacology 16, 9699.

46J Chen , XQ Tang , JL Zhi , (2006) Curcumin protects PC12 cells against 1-methyl-4-phenylpyridinium ion-induced apoptosis by bcl-2-mitochondria-ROS-iNOS pathway. Apoptosis 11, 943953.

47V Zbarsky , KP Datla , S Parkar , (2005) Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinson's disease. Free Radic Res 39, 11191125.

48N Pandey , J Strider , WC Nolan , (2008) Curcumin inhibits aggregation of alpha-synuclein. Acta Neuropathol 115, 479489.

49W Li , S Wang , J Feng , (2009) Structure elucidation and NMR assignments for curcuminoids from the rhizomes of Curcuma longa. Magn Reson Chem 47, 902908.

50Y Zeng , F Qiu , K Takahashi , (2007) New sesquiterpenes and calebin derivatives from Curcuma longa. Chem Pharm Bull (Tokyo) 55, 940943.

51DS Kim , SY Park & JK Kim (2001) Curcuminoids from Curcuma longa L. (Zingiberaceae) that protect PC12 rat pheochromocytoma and normal human umbilical vein endothelial cells from betaA(1–42) insult. Neurosci Lett 303, 5761.

52DS Kim & JY Kim (2001) Total synthesis of Calebin-A, preparation of its analogues, and their neuronal cell protectivity against beta-amyloid insult. Bioorg Med Chem Lett 11, 25412543.

53SY Park & DS Kim (2002) Discovery of natural products from Curcuma longa that protect cells from beta-amyloid insult: a drug discovery effort against Alzheimer's disease. J Nat Prod 65, 12271231.

54C Schiborr , GP Eckert , G Rimbach , (2010) A validated method for the quantification of curcumin in plasma and brain tissue by fast narrow-bore high-performance liquid chromatography with fluorescence detection. Anal Bioanal Chem 397, 19171925.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

British Journal of Nutrition
  • ISSN: 0007-1145
  • EISSN: 1475-2662
  • URL: /core/journals/british-journal-of-nutrition
Please enter your name
Please enter a valid email address
Who would you like to send this to? *